Examples
Worked examples
- Is an instance
An infectious disease epidemiologist evaluating Eurosurveillance for publishing rapid outbreak investigation findings, considering its 2025 Impact Factor (8.3, Q1 Infectious Diseases) and European surveillance readership.
- Is an instance
A university tenure committee assessing an epidemiological study published in Eurosurveillance, following DORA guidelines to evaluate the paper's outbreak methodologies rather than relying on the journal's impact factor.
Editorial commentary
Quick answer: Eurosurveillance holds a 2-year Journal Impact Factor (JIF) of 8.3 for the 2025 JCR data year (InCites Journal Citation Reports, Clarivate Analytics, released 2026), ranking #8 out of 141 journals (Q1) in the Infectious Diseases category. Published weekly by the European Centre for Disease Prevention and Control (ECDC), the journal operates as a Diamond Open Access outlet with no author fees and records a 2025 Scopus CiteScore of 13.6.
Overview and Editorial Scope
Eurosurveillance is a peer-reviewed, open-access scientific journal dedicated to the epidemiology, surveillance, prevention, and control of communicable diseases. Established in 1995 and published by the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, since 2007, the journal provides rapid-response outbreak communications, original research articles, surveillance reports, and policy analyses. The editorial office is led by Editor-in-Chief Dr. Ines Steffens (MD, MPH, DTM&PH) alongside an international editorial board representing public health agencies across Europe and international partner institutions.
The journal’s scope bridges primary laboratory science and population-level health response. Outbreak dispatches frequently synthesize genomic surveillance, such as cluster tracking via NCBI Pathogen Detection, with epidemiological case control studies. Because communicable disease management requires rigorous methodological foundations, understanding what is epidemiology clarifies how the observational and molecular studies published in Eurosurveillance translate into cross-border public health interventions.
Citation Metrics and Category Rankings
In Clarivate’s 2026 release of the Journal Citation Reports (covering 2025 citation data), Eurosurveillance received an impact factor of 8.3, maintaining its uninterrupted standing among the top 10 infectious disease journals since 2012. Like many specialized communicable disease journals, its citation numbers experienced an exceptional surge during the peak of the COVID-19 pandemic (exceeding 21 in 2021) before stabilizing into its long-term baseline between 8.0 and 9.0.
Complementary bibliometric indicators reflect similar visibility across multidisciplinary surveillance domains. In the Scopus database, Eurosurveillance holds a 2025 CiteScore of 13.6, placing it:
- #1 out of 43 journals in Immunology and Microbiology (miscellaneous) (98th percentile);
- #9 out of 173 journals in Epidemiology (95th percentile);
- #9 out of 86 journals in Virology (89th percentile);
- #18 out of 725 journals in Public Health, Environmental and Occupational Health (97th percentile); and
- #18 out of 361 journals in Infectious Diseases (95th percentile).
These dual rankings highlight the journal’s dual utility for infectious disease clinical specialists and broader population health professionals, concepts examined when analyzing epidemiology vs public health frameworks.
Publishing Model and Access
Eurosurveillance operates under a Diamond Open Access publishing model (often described as platinum open access). The journal is funded entirely by the ECDC, a European Union agency. Consequently, authors pay no article processing charges (APCs), submission fees, or color figure surcharges, and readers access all full-text articles immediately upon publication under Creative Commons licensing (CC BY 4.0). The publication is indexed comprehensively in MEDLINE/PubMed, PubMed Central (PMC), the Science Citation Index Expanded (SCIE), Scopus, and the Directory of Open Access Journals (DOAJ).
Responsible Use of Metrics
In alignment with the DORA (San Francisco Declaration on Research Assessment) and the Coalition for Advancing Research Assessment (CoARA), journal-level metrics such as the Journal Impact Factor or CiteScore reflect the aggregate citation frequency of a journal’s collective contents and must not serve as a proxy for the scientific quality or public health impact of any single investigation. Epidemiologists and hiring committees should evaluate individual surveillance dispatches on their empirical rigor, timeliness, and direct contribution to outbreak containment rather than the journal’s impact factor.
Sources
- Eurosurveillance. “About Us: Scope, Metrics and Indexing.” https://www.eurosurveillance.org/about (accessed 2026-11-07).
- European Centre for Disease Prevention and Control (ECDC). “Scientific Publications and Eurosurveillance.” https://www.ecdc.europa.eu/ (accessed 2026-11-07).
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Eurosurveillance"
vocab-term-identifier="https://casrai.org/dictionary/term/eurosurveillance" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/eurosurveillance",
"name": "Eurosurveillance",
"identifier": "https://casrai.org/dictionary/term/eurosurveillance",
"description": "Eurosurveillance is a Diamond Open Access, peer-reviewed scientific journal published weekly by the European Centre for Disease Prevention and Control (ECDC) covering communicable disease epidemiology, outbreak surveillance, and public health control, with a 2025 Clarivate Journal Impact Factor of 8.3 (Q1 Infectious Diseases) and Scopus CiteScore of 13.6.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/publishing#set",
"url": "https://casrai.org/dictionary/term/eurosurveillance",
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"author": {
"@id": "https://casrai.org/#editorial-team"
},
"datePublished": "2026-11-07T23:35:24",
"dateModified": "2026-11-07T23:35:24",
"inLanguage": "en-GB",
"isAccessibleForFree": true
}






